» Articles » PMID: 34268164

Retrospective Study and Outcome Predictor After Microsurgical Resection of Cerebral Arteriovenous Malformations in Nepal

Overview
Specialty Neurology
Date 2021 Jul 16
PMID 34268164
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study is to assess demographic, clinical, and morphological characteristics of patients with brain arteriovenous malformations (bAVMs). The relation of outcome using modified Ranklin Scale (mRS) at time of discharge, early and last follow ups with respect to various factors.

Materials And Methods: Demographic data, arteriovenous malformation characteristics, and treatment outcomes were evaluated in 43 bAVMs treated with microsurgery between 2009 and 2019. For this series, 43 patients were retrospectively reviewed. A subgroup analysis for Spetzler-Martin grades (SMG) I/II, III, IV/V and III-V were performed. The mRS was used to assess functional outcomes.

Results: Overall, mean age at diagnosis was 33 years (standard deviation = 19). Transient deficit, mRS deterioration and impaired functional outcome occurred less frequently in SMG I-II patients compared with Grade III-V patients combined (29% vs. 32% respectively, = 0.00). All patients with SMG Grade I, Supplemented SMG Grade 2, 3, 4 and 6 had a mRS score of 2 or less at the last follow-up. Age was the only significant predictor of overall outcome after bAVM surgery on Chi-square test ( = 0.046), i.e: all patients <20 years had mRS score of 2 or less on last follow-up. Unfavorable outcome (mRS score of 3 or more than 3) level increased with higher grades in SMG on long term follow-up.

Conclusion: The results of our case series of bAVM with SMG Grade I and Suplemented Grade 2, 3, 4 and even higher grade i.e., 6 can have excellent overall outcome after microsurgical resection. Association of factors which increases the grading system of bAVM like eloquence, deep venous drainage and increasing sizes did not correlate with the predicted unfavorable outcomes, whereas age of patients was a predictor of overall outcome. Although the small sample size of this study is a limitation, age of patient plays important role on the overall outcome.

Citing Articles

The Relationship Between Neuron-Specific Enolase and Clinical Outcomes in Patients Undergoing Mechanical Thrombectomy.

Peng Q, Chen W, E Y, Deng Y, Xu Z, Wang S Neuropsychiatr Dis Treat. 2023; 19:709-719.

PMID: 37038387 PMC: 10082584. DOI: 10.2147/NDT.S400925.

References
1.
Burkhardt J, Lasker G, Winkler E, Kim H, Lawton M . Microsurgical resection of brain arteriovenous malformations in the elderly: outcomes analysis and risk stratification. J Neurosurg. 2017; 129(5):1107-1113. PMC: 6816804. DOI: 10.3171/2017.6.JNS17392. View

2.
Al-Shahi R, Warlow C . A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain. 2001; 124(Pt 10):1900-26. DOI: 10.1093/brain/124.10.1900. View

3.
Ogilvy C, Stieg P, Awad I, Brown Jr R, Kondziolka D, Rosenwasser R . AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001; 32(6):1458-71. DOI: 10.1161/01.str.32.6.1458. View

4.
Kuhmonen J, Piippo A, Vaart K, Karatas A, Ishii K, Winkler P . Early surgery for ruptured cerebral arteriovenous malformations. Acta Neurochir Suppl. 2005; 94:111-4. DOI: 10.1007/3-211-27911-3_17. View

5.
Mohr J, Overbey J, Hartmann A, von Kummer R, Salman R, Kim H . Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol. 2020; 19(7):573-581. DOI: 10.1016/S1474-4422(20)30181-2. View